Duplogen Inc.

Duplogen was established in 2000 to join the bio-technology market. We are carrying out in-depth studies at the A-jou medical school with the ultimate goals of developing new treatment methods and supplies by using tissue engineering, genetic engineering, and biological techniques.  

We have produced cartilaginous cells that can be
used for autologous cell transplant. Furthermore, manufacturing of engineered cartilage products and technical development are in progress.

Our research will bear fruit by manufacturing various engineered products for all the internal organs of
the human body.  Duplogen plans to expand its works on tissue engineering methods by incorporating genetic engineering, and thereby embody an unchallenged skill in its field. This will be made possible through our vigorous research in genetics treatment.

Duplogen performs its research at home and abroad by studying with prestigious universities to maintain it
s exceptional standards. Duplogen strives to perform a leading role in the industry by expanding the developed technologies and methods professionally.